Tyra Biosciences (TYRA) Other Non-Current Assets (2020 - 2026)

Tyra Biosciences has reported Other Non-Current Assets for 7 years, with the latest figure at $884000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 11.6% year-over-year to $884000.0; the trailing twelve-month figure through Mar 2026 stood at $884000.0 (down 11.6% YoY), and the FY2025 full-year result was $1.0 million, changed 0.0% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $884000.0, down from $1.0 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $11.1 million in Q2 2025, with the low at $362000.0 in Q1 2022.
• Historically, Other Non-Current Assets has averaged $2.2 million across 5 years, with a median of $1.0 million in 2022.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets sank 82.96% — and 2025, when it surged 1010.9%.
• Tyra Biosciences' Other Non-Current Assets stood at $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025, then decreased by 11.6% to $884000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $884000.0 (Q1 2026), $1.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.